For women of childbearing age facing symptomatic uterine fibroids, the question of fertility often weighs heavily in treatment decisions. The desire to relieve debilitating symptoms must be balanced against the hope of future pregnancy, creating a complex decision-making process that requires careful consideration of treatment options and their potential impact on reproductive capacity. While hysterectomy permanently ends the possibility of pregnancy, uterine fibroid embolization preserves the uterus and has allowed many women to successfully conceive and carry healthy pregnancies after treatment. Understanding the relationship between UFE and fertility, the factors that influence pregnancy outcomes, and alternative treatment approaches empowers women to make informed choices that align with both their immediate symptom relief needs and their long-term family planning goals.
Key Takeaways
- UFE preserves the uterus and maintains the anatomical possibility of future pregnancy
- Many women have successfully conceived and delivered healthy babies after UFE
- Pregnancy success after UFE depends on age, fibroid characteristics, and overall reproductive health
- UFE is not specifically designed as a fertility treatment but can improve conception chances by reducing fibroid burden
- Women planning pregnancy in the near future should discuss timing and alternatives with their physician
- Myomectomy remains the preferred option for women actively trying to conceive
- Comprehensive fertility evaluation helps determine the best treatment approach for individual circumstances
Understanding UFE’s Impact on Fertility
Uterine fibroid embolization works by blocking blood flow to fibroids, causing them to shrink while preserving the uterus itself. This fundamental preservation of the uterus means that unlike hysterectomy, UFE does not automatically eliminate the possibility of future pregnancy. The procedure targets only the blood vessels feeding the fibroids, and while some reduction in overall uterine blood flow can occur, the uterus typically maintains adequate blood supply through collateral circulation from other arterial sources. This allows the uterine tissue to remain viable and potentially capable of supporting a pregnancy.
However, the relationship between UFE and fertility is more nuanced than simple uterus preservation. The procedure does cause changes to the uterine environment, and these changes can affect reproductive capacity in ways that vary among individual women. The embolic beads used during UFE are designed to lodge specifically in the small blood vessels supplying fibroids, but some beads may inadvertently affect blood flow to the endometrium—the uterine lining where embryos implant—or to the ovaries. Additionally, the inflammatory response that occurs as fibroids break down after embolization can potentially cause scarring or adhesions within the uterine cavity, though this is relatively uncommon.
At Texas I.R. Interventional Oncology, Dr. Rafiei uses advanced imaging guidance and precise catheter placement techniques to minimize any impact on healthy uterine tissue and optimize outcomes for women who hope to preserve their fertility. His extensive experience with thousands of embolization procedures ensures the highest level of technical skill and attention to fertility considerations during treatment planning and execution.
Pregnancy Success Rates After UFE
Research on pregnancy outcomes after UFE provides encouraging evidence that conception and successful pregnancy are achievable for many women following the procedure. Multiple studies have documented successful pregnancies after UFE, with live birth rates ranging from forty-five to seventy percent among women who attempt to conceive after treatment. These rates are comparable to pregnancy success rates in women with untreated fibroids, suggesting that for many women, UFE does not significantly impair fertility and may actually improve it by reducing the fibroid burden that was interfering with conception or pregnancy maintenance.
The success of pregnancy after UFE depends on multiple factors beyond the procedure itself. A woman’s age at the time of treatment significantly influences fertility outcomes, as age-related decline in egg quality and ovarian reserve affects all women regardless of fibroid treatment. Women under thirty-five generally have better pregnancy success rates after UFE than those over forty, reflecting natural fertility patterns. The size, number, and location of fibroids also matter—women with fewer, smaller fibroids typically have better fertility outcomes than those with large or numerous fibroids, both before and after treatment.
The time interval between UFE and attempted conception also plays a role in success rates. Most physicians recommend waiting at least three to six months after UFE before attempting pregnancy to allow complete healing of the uterine tissue and full fibroid shrinkage. This waiting period ensures that the inflammatory response has resolved and the uterine environment has stabilized, creating optimal conditions for embryo implantation and early pregnancy development. Women who become pregnant too soon after UFE may face increased risks of complications, though successful early pregnancies have been reported.
Comparing UFE with Other Fertility-Preserving Treatments
When fertility preservation is a primary concern, it’s important to understand how UFE compares with other treatment options that also maintain the possibility of future pregnancy. Myomectomy, the surgical removal of fibroids while leaving the uterus intact, has traditionally been considered the gold standard fertility-preserving fibroid treatment for women actively trying to conceive. Myomectomy directly removes problematic fibroids, particularly submucosal fibroids that protrude into the uterine cavity and interfere with implantation, potentially improving fertility more predictably than UFE.
However, myomectomy comes with its own set of considerations and limitations. The procedure requires surgery, either through laparoscopic or open abdominal approach, with associated surgical risks, longer recovery time, and potential for complications including excessive bleeding, infection, and adhesion formation. Adhesions from myomectomy can actually impair fertility by affecting fallopian tube function or creating barriers within the pelvis. Additionally, fibroids can recur after myomectomy, with recurrence rates of ten to thirty percent over five to ten years, potentially necessitating additional surgery.
For women who are not actively trying to conceive immediately but want to preserve future fertility options, UFE offers several advantages over myomectomy. The minimally invasive nature of UFE means faster recovery, lower complication rates, and the ability to treat multiple fibroids throughout the uterus in a single procedure without the limitations imposed by surgical access. Women can undergo UFE, allow time for healing and fibroid shrinkage, and then attempt conception when they’re ready, having addressed their fibroid symptoms without the extended recovery and surgical risks of myomectomy.
Watchful waiting represents another option for women with fibroids who are actively trying to conceive. If fibroids are not causing severe symptoms and are not clearly interfering with fertility, some women choose to attempt pregnancy without treatment, addressing fibroids only if pregnancy doesn’t occur or if symptoms become intolerable. This approach avoids any potential treatment-related impact on fertility but leaves women dealing with fibroid symptoms and the possibility that fibroids may grow during pregnancy, potentially causing complications.
Special Considerations for Women Planning Pregnancy
If you’re considering UFE and hope to become pregnant in the future, several important factors deserve discussion with your physician during treatment planning. First, the specific characteristics of your fibroids—their size, number, and particularly their location—influence both the appropriateness of UFE and the likely impact on fertility. Submucosal fibroids that bulge into the uterine cavity have the greatest impact on fertility and pregnancy outcomes. While UFE can shrink these fibroids, surgical removal via hysteroscopic myomectomy may offer more predictable improvement in fertility for women with predominantly submucosal fibroids.
Second, your timeline for attempting pregnancy matters significantly. If you plan to try to conceive within the next six to twelve months, myomectomy may be preferable to UFE despite its more invasive nature, as it provides a more established track record for fertility outcomes and allows pregnancy attempts sooner after the recommended healing period. If your pregnancy plans are further in the future or less certain, UFE’s advantages of minimal invasiveness and faster recovery may outweigh the theoretical fertility considerations, particularly if your primary goal is symptom relief with fertility preservation as a secondary concern.
Third, comprehensive fertility evaluation before fibroid treatment helps clarify whether fibroids are actually contributing to fertility challenges or whether other factors may be more significant. If fertility testing reveals issues such as ovulation disorders, tubal blockage, male factor infertility, or diminished ovarian reserve, addressing these factors may be more important for achieving pregnancy than fibroid treatment. In such cases, UFE’s symptom relief benefits can be achieved while other fertility issues are simultaneously addressed through assisted reproductive technologies or other interventions.
Pregnancy Outcomes and Risks After UFE
For women who do become pregnant after UFE, understanding potential pregnancy-related considerations helps ensure optimal prenatal care and outcomes. Most women who conceive after UFE have uncomplicated pregnancies and deliver healthy babies at term. However, some studies suggest slightly increased rates of certain pregnancy complications including miscarriage, preterm delivery, and abnormal placentation compared to women without fibroids or fibroid treatment. It’s important to note that women with fibroids—whether treated or untreated—have higher baseline risks for these complications compared to women without fibroids, making it difficult to determine whether UFE itself or the underlying fibroid condition contributes to these risks.
Cesarean delivery rates appear somewhat higher in women who have undergone UFE compared to the general population, though again, this may reflect the presence of fibroids rather than the UFE procedure specifically. Some physicians recommend cesarean delivery for women who have had UFE due to theoretical concerns about uterine integrity during labor, though vaginal delivery has been accomplished successfully in many cases. Close monitoring during pregnancy and delivery by obstetricians experienced with high-risk pregnancies ensures the best outcomes for both mother and baby.
The possibility of fibroid regrowth during pregnancy represents another consideration. Pregnancy hormones, particularly estrogen, can stimulate fibroid growth, and some women experience enlargement of residual fibroids or development of new fibroids during pregnancy. While this doesn’t always cause problems, it can occasionally lead to pain, preterm labor, or other complications requiring management during pregnancy.
Making an Informed Decision About Your Fertility and Treatment
Deciding how to address symptomatic fibroids while preserving fertility options requires balancing multiple competing priorities and accepting some degree of uncertainty about future outcomes. No fibroid treatment can guarantee future pregnancy success, just as no treatment can guarantee that fertility will be completely unaffected. The decision must account for your current symptom severity, your timeline and certainty regarding future pregnancy plans, your age and overall fertility status, and your personal tolerance for different types of risk and intervention.
At Texas I.R., the approach emphasizes thorough discussion of all options, honest presentation of available evidence regarding fertility outcomes, and collaborative decision-making that respects each woman’s unique circumstances and values. To explore whether UFE might be appropriate for your situation, or to discuss alternative approaches for addressing fibroids while preserving fertility, contact women’s health in Katy to schedule a consultation.
As you continue exploring content about interventional radiology treatments, the next month’s series will address How to Know If Your Prostate is Enlarged: Common BPH Symptoms Men Shouldn’t Ignore, shifting focus to men’s health concerns that can also benefit from minimally invasive interventional approaches.
Your Fertility Matters
Fibroid treatment doesn’t have to mean sacrificing your dreams of future pregnancy. With careful treatment selection, expert care, and realistic expectations, you can address debilitating symptoms while maintaining your reproductive options and moving forward with confidence in your health decisions.